secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001001233-25-000015
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo gets Nasdaq extension to April 27, 2026 to meet $1.00 bid price
-----------------------------------------------------------------------

- Received 180-day extension from Nasdaq until April 27, 2026 to regain minimum bid price compliance.
- Must close at $1.00+ for 10 consecutive trading days to cure deficiency.
- Original non-compliance notice was dated April 30, 2025; first cure deadline was Oct 27, 2025.
- Failure to cure by April 27, 2026 will trigger delisting notice; company may appeal.
- No assurance of regaining compliance; shares continue trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000100123325000015/0001001233-25-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000100123325000015/sgmo-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001001233-25-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer